AI-generated summary
The authors tested low-level laser therapy delivered by a minimally invasive laser needle system in ovariectomized mice, which had osteoporotic bone loss. Eight mice received laser treatment to the tibia and eight received a sham treatment, with trabecular bone measured by in vivo micro-computed tomography before and after two weeks. The authors report that laser treatment was associated with less loss in some trabecular measures than sham, and suggest it may help prevent or treat trabecular bone loss in mice.
- Who or what was studied
- Ovariectomized mice with induced osteoporotic bone loss (eight laser-treated, eight sham-treated)
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study used a small number of mice, animal rather than human data, and the abstract notes the effect may be site-dependent within the same bone.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on iopscience.iop.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Total energy
- 3 J
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Sham. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.